The latest research study “Apheresis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that The global apheresis market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.55% during 2023-2028.
What is Apheresis Market?
Apheresis represents the procedure of separating donated blood components, such as white blood cells (WBCs), platelets, red blood cells (RBCs), and plasma, to treat various diseases. It assists in treating sickle cell conditions wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen throughout the body. Apheresis is also utilized to remove irregular white blood cells (WBCs) that thicken the blood and hinder organ function. In addition, it aids in treating blood cancers and disorders, including myasthenia gravis and thrombotic thrombocytopenic purpura (TTP). As a result, apheresis finds widespread applications in blood collection centers, hospitals, and ambulatory centers across the globe.
Request a free sample brochure: https://www.imarcgroup.com/apheresis-market/requestsample
Apheresis Market Trends and Drivers:
The escalating demand for this procedure to treat several diseases, such as acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and neonatal cardiac lupus is among the primary factors driving the apheresis market. Besides this, the extensive utilization of this technique to collect plasma for treating burnt and trauma patients across the globe and the expanding healthcare industry are further augmenting the market growth. Moreover, the growing popularity of apheresis as a therapy for various conditions, including hemolytic uremic syndrome, drug toxicities, autoimmune disease, thrombotic thrombocytopenic purpura, sepsis, and fulminant hepatic failure, is also catalyzing the global market. Apart from this, the increasing investments by the leading players in research and development (R&D) activities to introduce an enhanced blood purification device that ministers severe forms of arteriosclerosis obliterans are acting as significant growth-inducing factors. Additionally, the rising awareness among the masses toward the benefits of this procedure is also stimulating the market growth. Furthermore, the elevating requirement for source plasma to treat primary immunodeficiency and hemophilia is anticipated to propel the apheresis market over the forecasted period.
Click here to view detailed information with table of content: https://www.imarcgroup.com/apheresis-market
Apheresis Market Report Segmentation:
List of Major Key Players:
The major players in the market are
Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), B. Braun SE, Charles River Laboratories International Inc., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Kaneka Corporation, Medica S.p.a., Miltenyi Biotec, Nikkiso Co. Ltd., Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) and Terumo Bct Inc. (Terumo Corporation).
The report has been segmented the market into following categories:
Breakup by Component:
- Plasma (Plasmapheresis)
- Platelets (Plateletpheresis)
- Leukocytes (Leukapheresis or Leukopheresis)
- Lymphocytes (Lymphopheresis or Lymphapheresis)
- RBC's (Erythropheresis)
Breakup by Product:
- Devices
- Disposables and Reagents
- Software
Breakup by Technology:
- Centrifugation
- Membrane Separation
- Selective Adsorption
Breakup by Procedure:
- Donor/Automated Apheresis
- Therapeutic Apheresis
Breakup by Application:
- Renal Disorders
- Hematological Disorders
- Neurological Disorders
- Autoimmune Disorders
- Others
Breakup by End User:
- Blood Centers
- Hospitals
- Others
By Geography:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800